{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:53:54Z","timestamp":1767923634525,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472800"],"award-info":[{"award-number":["81472800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shandong University of Science and Technology of Shandong Province","award":["2013GGE27052"],"award-info":[{"award-number":["2013GGE27052"]}]},{"name":"Shandong University of Science and Technology of Shandong Province","award":["2014GGH218010"],"award-info":[{"award-number":["2014GGH218010"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["DNA Repair"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.dnarep.2017.08.002","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T19:01:39Z","timestamp":1502305299000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Valproic acid sensitizes breast cancer cells to hydroxyurea through inhibiting RPA2 hyperphosphorylation-mediated DNA repair pathway"],"prefix":"10.1016","volume":"58","author":[{"given":"Youjia","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guochao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhujun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuchao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gongshe","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.dnarep.2017.08.002_bib0005","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1158\/0008-5472.CAN-05-0487","article-title":"Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo","volume":"66","author":"Xia","year":"2006","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.dnarep.2017.08.002_bib0010","first-page":"787","article-title":"Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation","volume":"37","author":"Kawano","year":"2010","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.dnarep.2017.08.002_bib0015","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1002\/cncr.23433","article-title":"Valproic acid for the treatment of myeloid malignancies","volume":"112","author":"Shah","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.dnarep.2017.08.002_bib0020","first-page":"47","article-title":"Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents","volume":"7","author":"Ververis","year":"2013","journal-title":"Biologics"},{"issue":"1","key":"10.1016\/j.dnarep.2017.08.002_bib0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"West","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.dnarep.2017.08.002_bib0030","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1158\/1535-7163.MCT-08-0860","article-title":"Epigenetics in cancer: targeting chromatin modifications","volume":"8","author":"Ellis","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.dnarep.2017.08.002_bib0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4161\/epi.1.3.2896","article-title":"The epigenetic modifier, valproic acid, enhances radiation sensitivity","volume":"1","author":"Karagiannis","year":"2006","journal-title":"Epigenetics"},{"issue":"4","key":"10.1016\/j.dnarep.2017.08.002_bib0040","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4161\/cc.7.4.5405","article-title":"Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments","volume":"7","author":"Harikrishnan","year":"2008","journal-title":"ABBV Cell Cycle"},{"issue":"2","key":"10.1016\/j.dnarep.2017.08.002_bib0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/bdrb.20236","article-title":"Characterization of valproic acid-initiated homologous recombination","volume":"89","author":"Sha","year":"2010","journal-title":"Birth Defects Res. B Dev. Reprod. Toxicol."},{"issue":"3","key":"10.1016\/j.dnarep.2017.08.002_bib0050","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1039\/C5TX00476D","article-title":"Valproic acid causes radiosensitivity of breast cancer cells via disrupting the DNA repair pathway","volume":"5","author":"Luo","year":"2016","journal-title":"Toxicol. Res."},{"issue":"1","key":"10.1016\/j.dnarep.2017.08.002_bib0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/blood.V69.1.109.109","article-title":"Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia","volume":"69","author":"Charache","year":"1987","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.dnarep.2017.08.002_bib0060","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia: investigators ofthe Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.dnarep.2017.08.002_bib0065","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.onc.1210677","article-title":"Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis","volume":"27","author":"Kramer","year":"2008","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.dnarep.2017.08.002_bib0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.18632\/oncotarget.430","article-title":"A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer","volume":"3","author":"Stauber","year":"2012","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.dnarep.2017.08.002_bib0075","doi-asserted-by":"crossref","first-page":"8105","DOI":"10.18632\/oncotarget.6991","article-title":"Hydroxyurea synergizes with valproic acid in wild-type p53 acute myeloid leukaemia","volume":"7","author":"Leitch","year":"2016","journal-title":"Oncotarget"},{"issue":"66","key":"10.1016\/j.dnarep.2017.08.002_bib0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.biochem.66.1.61","article-title":"Replication protein A: a heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism","volume":"66","author":"Wold","year":"1997","journal-title":"Annu. Rev. Biochem."},{"issue":"8\u20139","key":"10.1016\/j.dnarep.2017.08.002_bib0085","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.dnarep.2004.03.028","article-title":"Replication protein A phosphorylation and the cellular response to DNA damage","volume":"3","author":"Binz","year":"2004","journal-title":"DNA Repair (Amst)"},{"issue":"49","key":"10.1016\/j.dnarep.2017.08.002_bib0090","doi-asserted-by":"crossref","first-page":"35910","DOI":"10.1074\/jbc.M704645200","article-title":"Sequential and synergistic modification of human RPA stimulates chromosomal DNA repair","volume":"282","author":"Anantha","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"35","key":"10.1016\/j.dnarep.2017.08.002_bib0095","doi-asserted-by":"crossref","first-page":"12903","DOI":"10.1073\/pnas.0803001105","article-title":"RPA phosphorylation facilitates mitotic exit in response to mitotic DNA damage","volume":"105","author":"Anantha","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"21","key":"10.1016\/j.dnarep.2017.08.002_bib0100","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1128\/MCB.00191-09","article-title":"Protein phosphatase 2A-dependent dephosphorylation of replication protein A is required for the repair of DNA breaks induced by replication stress","volume":"29","author":"Feng","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.dnarep.2017.08.002_bib0105","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1042\/BJ20050379","article-title":"Preferential localization of hyperphosphorylated replication protein A to double-strand break repair and checkpoint complexes upon DNA damage","volume":"391","author":"Wu","year":"2005","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.dnarep.2017.08.002_bib0110","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/carcin\/bgq035","article-title":"The role of RPA2 phosphorylation in homologous recombination in response to replication arrest","volume":"31","author":"Shi","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.dnarep.2017.08.002_bib0115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.dnarep.2015.06.005","article-title":"p53 suppresses hyper-recombination by modulating BRCA1 function","volume":"33","author":"Dong","year":"2015","journal-title":"DNA Repair (Amst)"},{"issue":"8","key":"10.1016\/j.dnarep.2017.08.002_bib0120","doi-asserted-by":"crossref","first-page":"915","DOI":"10.5858\/2002-126-0915-HCOMNL","article-title":"Histopathologic characterization of mammary neoplastic lesions induced with 7,12 dimethylbenz (alpha) anthracene in the rat: a comparative analysis with human breast tumors","volume":"126","author":"Costa","year":"2002","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"11","key":"10.1016\/j.dnarep.2017.08.002_bib0125","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3760\/cma.j.issn.0366-6999.20130276","article-title":"Establishment of novel rat models for premalignant breast disease","volume":"127","author":"Wang","year":"2014","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"2","key":"10.1016\/j.dnarep.2017.08.002_bib0130","first-page":"91","article-title":"Genistein and daidzein, in combination, protect cellular integrity during 7, 12-dimethylbenz[a]anthracene (DMBA) induced mammary carcinogenesis in Sprague-Dawley rats","volume":"8","author":"Pugalendhi","year":"2011","journal-title":"Afr. J. Traditional Complementary Alternative Med., AJTCAM"},{"issue":"9","key":"10.1016\/j.dnarep.2017.08.002_bib0135","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.dnarep.2017.08.002_bib0140","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.molcel.2010.01.021","article-title":"Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair","volume":"37","author":"Petermann","year":"2010","journal-title":"Mol. Cell"},{"issue":"19","key":"10.1016\/j.dnarep.2017.08.002_bib0145","doi-asserted-by":"crossref","first-page":"12634","DOI":"10.1074\/jbc.272.19.12634","article-title":"Mapping of amino acid residues in the p34 subunit of human single-stranded DNA-binding protein phosphorylated by DNA-dependent protein kinase and Cdc2 kinase in vitro","volume":"272","author":"Niu","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.dnarep.2017.08.002_bib0150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1586\/era.11.175","article-title":"Hydroxyurea: a key player in cancer chemotherapy","volume":"12","author":"Madaan","year":"2012","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"5","key":"10.1016\/j.dnarep.2017.08.002_bib0155","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3390\/ijms18051027","article-title":"The effect of VPA on increasing radiosensitivity in osteoscarcoma cells and primary-culture cells from chemical carcinogen-induced breast cancer in rats","volume":"18","author":"Liu","year":"2017","journal-title":"Int. J. Mol. Sci."}],"container-title":["DNA Repair"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156878641730023X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156878641730023X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T03:08:04Z","timestamp":1719371284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156878641730023X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":31,"alternative-id":["S156878641730023X"],"URL":"https:\/\/doi.org\/10.1016\/j.dnarep.2017.08.002","relation":{},"ISSN":["1568-7864"],"issn-type":[{"value":"1568-7864","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid sensitizes breast cancer cells to hydroxyurea through inhibiting RPA2 hyperphosphorylation-mediated DNA repair pathway","name":"articletitle","label":"Article Title"},{"value":"DNA Repair","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dnarep.2017.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}